Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 10,757 | 9,588 | N/A | N/A |
| Marketable Securities | 5,373 | 3,736 | N/A | N/A |
| TOTAL | $16,334 | $13,386 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 515 | 19 | N/A | N/A |
| Investments And Advances | 518 | 802 | 0 | 0 |
| Other Non-Current Assets | 10 | 0 | 0 | 0 |
| TOTAL | $1,043 | $821 | $N/A | $N/A |
| Total Assets | $17,377 | $14,207 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,263 | 353 | 0 | 0 |
| Accrued Expenses | 188 | 14 | N/A | N/A |
| TOTAL | $1,451 | $367 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $4 | $3 | $N/A | $N/A |
| Total Liabilities | $1,455 | $370 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -20,749 | -9,166 | N/A | N/A |
| Other shareholders' equity | 36,671 | 23,003 | 0 | 0 |
| TOTAL | $15,922 | $13,837 | $N/A | $N/A |
| Total Liabilities And Equity | $17,377 | $14,207 | $0 | $0 |